ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
FDA Approves Four Generic Forms of Zidovudine for U.S. Sales After Retrovir's Patent Expires
FDA on Monday announced it has granted approval for four forms of the generic antiretroviral drug zidovudine to be sold in the U.S., after GlaxoSmithKline's patent on the drug -- sold under the brand name Retrovir -- expired on Saturday, Dow Jones reports. The agency gave full approval to a generic zidovudine oral solution made by India-based Aurobindo Pharma and generic zidovudine tablets made by Aurobindo, India-based Ranbaxy Laboratories and Columbus, Ohio-based Roxane Laboratories (Corbett Dooren, Dow Jones, 9/19). FDA already had given tentative approval to all of the drugs for inclusion under the President's Emergency Plan for AIDS Relief (FDA release, 9/19). The tentative approval designation meant that the generic drugs met FDA safety and efficacy standards but could not be sold in the U.S. because of existing patents or exclusivity agreements (Kaiser Daily HIV/AIDS Report, 9/12). The drugs are the first generic versions of Retrovir to be approved for marketing in the U.S. (Bloomberg News, 9/19). GSK does not expect its revenue to be affected by the patent expiration because it will not affect the price of Combivir and Trizivir, its newest drugs containing zidovudine, which in 2004 brought in combined sales of $1.6 billion (Kaiser Daily HIV/AIDS Report, 9/20).
Blue Cross and Blue Shield Association:
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
View drug information on Combivir; Trizivir.
FDA aprobã Patru Generic formelor de Zidovudine pentru SUA Vanzari Dupã Retrovir lui Patent Expirã - FDA Approves Four Generic Forms of Zidovudine for U.S. Sales After Retrovir's Patent Expires - articole medicale engleza - startsanatate
